Suchergebnisse - "Zhuang, Meng-Wei"

PubPharm (14)

1

SARS-CoV-2 ORF10 antagonizes STING-dependent interferon activation and autophagy

enthalten in: Journal of medical virology | 2022

von Han, L. | Zheng, Y. | Deng, J. | +7

2

SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules

enthalten in: Signal transduction and targeted therapy | 2022

von Zheng, Y. | Deng, J. | Han, L. | +9

3

An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity

enthalten in: Cell chemical biology | 2022

von Zhang, Y. | Shang, L. | Zhang, J. | +16

4

SARS‐CoV‐2 ORF10 antagonizes STING‐dependent interferon activation and autophagy

enthalten in: Journal of Medical Virology | 2022

von Han, L. | Zheng, Y. | Deng, J. | +7

5

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Membrane (M) Protein Inhibits Type I and III Interferon Production by Targeting RIG-I/MDA-5 Signaling

enthalten in: bioRxiv.org | 2021

von Zheng, Y. | Zhuang, M. | Han, L. | +4

6

A Systemic and Molecular Study of Subcellular Localization of SARS-CoV-2 Proteins

enthalten in: bioRxiv.org | 2021

von Zhang, J. | Cruz-cosme, R. | Zhuang, M. | +5

7

SARS-CoV-2 ORF9b Antagonizes Type I and III Interferons by Targeting Multiple Components of RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING Signaling Pathways

enthalten in: bioRxiv.org | 2021

von Han, L. | Zhuang, M. | Zheng, Y. | +4

8

SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways

enthalten in: Journal of medical virology | 2021

von Han, L. | Zhuang, M. | Deng, J. | +6

9

Correction : A systemic and molecular study of subcellular localization of SARS-CoV-2 proteins

enthalten in: Signal transduction and targeted therapy | 2021

von Zhang, J. | Cruz-Cosme, R. | Zhuang, M. | +5

ErratumFor: Signal Transduct Target Ther. 2020 Nov 17;5(1):269. - PMID 33203855

10

SARS‐CoV‐2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG‐I/MDA‐5–MAVS, TLR3–TRIF, and cGAS–STING signaling pathways

enthalten in: Journal of Medical Virology | 2021

von Han, L. | Zhuang, M. | Deng, J. | +6